Cell suspensions derived from a mouse plasmacytoma that secretes an immunoglobulin light chain containing N-terminal pyroglutamic acid can synthesize protein in vitro. Chromatographic examination of an enzymatic digest of protein labeled with glutamic acid shows only labeled glutamic acid and pyroglutamic acid; hydrolysis of protein from cells labeled with glutamine, however, yields substantial amounts of glutamic acid in addition to glutamine and pyroglutamic acid. The absence of glutamine synthetase and presence of glutaminase in plasmacytoma homogenates is consistent with these findings. These data indicate that N-terminal pyroglutamic acid can be derived from glutamic acid without prior conversion of glutamic acid to glutamine. Since free or bound forms of glutamine cyclize nonezymatically to pyroglutamate with ease, while glutamic acid does not, the data suggest that N-terminal pyroglutamic acid formation from glutamic acid is enzymatic rather than spontaneous.
initiated by the addition of radioactive amino acids.
Enzyme Assays. Preparation of homogenates and reaction mixtures for the radiochemical assay of glutamine synthetase (EC 6.3.1.2) were as described by Lund (15) . Glutaminase (EC 3.5.1.2) activity was measured by a modification of the glutamine synthetase assay, with radioactive glutamine as the substrate. The loss of radioactivity in the effluent from a Dowex-1 column was a measure of the enzyme activity.
Pyroglutamic acid (pyrrolidone carboxylic acid; pGlu) is found as the N-terminal amino acid in various proteins and polypeptides. It has been demonstrated in both immunoglobulin light and heavy chains (1), fibrinogen (2) , and collagen (3), as well as in kinins and venoms (4) . Although pGlu has a blocked amino group and a structure about its a-carbon atom similar to that of N-formylmethionine, there is no convincing evidence implicating it in the initiation process. Since pGlu cannot be acylated directly to transfer RNA (5, 6) , attempts have been made to demonstrate a mechanism for pGlu formation in proteins similar to the formylation of methionine on fMet-tRNA (7, 8) . Preliminary studies demonstrating that pGlu is formed from glutaminyltRNA (9) or from N-terminal glutamine (10) are available, but the spontaneous cyclization of glutamine to pGlu (11) makes the interpretation of these data difficult. This tendency of glutamine and N-terminal glutaminyl peptides to form pGlu under mild conditions has introduced some reservations as to whether pGlu is present in native protein or is derived from the spontaneous cyclization of glutamine (11) .
We report here experiments that identify the precursor of N-terminal pGlu in plasmacytoma protein. A preliminary report of this work has been published (12 (Fig. 1) . Substantial incorporation was observed for glutamine, glutamic acid, leucine, histidine, and methionine. The great difference in the extent of incorporation of glutamine compared to leucine and glutamic acid, as shown on the semilogarithmic plot, probably is due to differences in uptake rates or pool sizes in the cells. The data of Fig. 2 support this idea. As shown in the bar graph, the addition of unlabeled glutamine to cell suspensions stimulated the incorporation of glutamic acid and leucine. This stimulation was not observed for the other amino acids tested. This is in keeping with the greater requirement for glutamine than for other amino acids for the growth of L cells and HeLa cells in tissue culture (16 (10 , uCi) , in the presence of an equimolar amount of cold glutamic acid. After 90 min of incubation at 37°C, the cell suspensions were frozen and thawed to break the cells, concentrated by lyophilization, dialyzed extensively against H20, and again lyophilized. The relyophilized material was then suspended in 2 ml of 0.05 M Tris-HC1 (pH 8.0) and digested with Pronase (Calbiochem, 100 mg, 4500 proteolytic units) for 24 hr at 370C. Any remaining insoluble material was removed by centrifugation.
A preliminary analysis of protein hydrolyzates from each cell incubation was made on Dowex-50 columns. pGlu, which has a blocked amino group, is not retained on the negativelycharged resin and is found in the effluent. About 10% of the radioactivity derived from protein labeled with either glutamine or glutamic acid was found in the effluent ( Table 1 The bar graph schematizes, from left to right, the incorporation of glutamic acid, glutamine, and leucine into hotacid-precipitable material. Experimental details were as in Fig. 1 . The 100% value for incorporation represents the maximum value of incorporation achieved in 90 min for each radioactive amino acid in a complete incubation medium as described in Fig. 1 . Where indicated by a minus sign, the incubation medium was deficient in that amino acid. Samples were assayed for incorporation of radioactivity into protein as in Fig. 1. ic acid or ['4C]glutamine. Chromatography of the hydrolyzate from cells labeled with glutamic acid (Fig. 3 , upper panel) demonstrated that only glutamic acid and pGlu were labeled. There was no evidence of conversion of glutamic acid!to glutamine. In contrast, an examination of the protein hydrolyzate from cells labeled with glutamine (Fig. 3, lower panel) showed substantial amounts of labeled glutamic acid and glutamine, in addition to pGlu. We suggest therefore that the pGlu in protein from glutamate-labeled cells is derived from glutamic acid without the intervention of a glutamine intermediate.
Enzyme activities in plasmacytoma and liver homogenates
The above hypothesis is supported by a survey of glutamine synthetase and glutaminase activity in plasmacytoma cell extracts. The results of Fig. 4 (upper panel) indicate that glutamine synthetase activity was not detectable in plasmacytoma homogenates, whereas substantial activity was seen in mouse liver. On the other hand, a very active glutaminase activity (Fig. 4, lower panel) was observed in plasmacytoma 
DISCUSSION
This study has focused attention on two interrelated questions: whether glutamic acid or glutamine is the more direct precursor of pGlu in protein, and whether N-terminal pGlu formation in immunoglobulins is a biological or artifactual process. A metabolic distinction between glutamic acid and glutamine is difficult in many tissues because of the enzymatic interconversion of the two amino acids catalyzed by glutamine synthetase or glutaminase. Thus, while this study might have been complicated in other tissues, the unique properties of the plasmacytoma extracts allowed us to obtain interpretable results. The absence of glutamine synthetase (Fig. 4) prevents glutamine formation from glutamic acid (Fig. 3,  upper panel) , although the glutaminase present does not suppress glutamic acid formation from glutamine. These data are consistent with previous observations that mammalian cells in culture have a glutamine requirement that cannot be replaced by glutamic acid (16) .
The artifactual formation of pGlu occurs primarily with glutamine, and not with glutamic acid. Table 2 emphasizes this distinction between glutamic acid and glutamine. Neither glutamic acid nor glutamyl-tRNA formed significant amounts of pGlu after incubation at pH 8.0 and 370C. On the other hand, about 8% of the added glutamine was recovered as pGlu after 18 hr under these conditions. The nonenzymatic cyclization of glutamine probably explains the finding (Table 1) that pGlu was recovered from hydrolyzates of glutamine-labeled protein (10% after 24 hr at pH 8.0). When the a-carboxyl group of glutamine was esterified (glutaminyl-tRNA), the nonenzymatic cyclization was accelerated about 4- Homogenates from liver and plasmacytomas were prepared in 4 volumes of 0.05 M Tris-HCl, (pH 7.5)-5 mM EDTA-0.9% NaCl. Cellular debris was removed by centrifugation at 10,000 X g, and the supernatant was used for both the glutamine synthetase and glutaminase assay. Incubation mixtures for the glutamine synthetase assay (top) were as described by Lund (15) ; glutaminase was assayed (bottom) in 0.05 M Tris -HCl (pH 8.5). Reaction mixtures from both assays were equilibrated to 370C and reactions were started by addition of the crude homogenate. Samples were withdrawn at various times and pipetted into 0.25 ml of cold 95% ethanol; the precipitate was removed by centrifugation and the supernatants were assayed on Dowex-50 columns. different possible interpretations of our precursor studies. If we had found that glutamine was the precursor to pGlu, we would be uncertain whether the isolated pGlu had been formed by an enzymatic or nonenzymatic process. Since the data suggested that pGlu was derived from glutamic acid, the interpretation was greatly simplified. We can, therefore, assume that an enzymatic process is necessary for the cyclization of glutamic acid to pGlu. (15 Ci/,umol), 5 ,Ci/ml. After incubation for 15 min, the mixture was applied to a column (1.3 X 4 cm) of DEAE-cellulose, and the column was washed with about 25 ml of 0.3 M NaCl containing 0.1 M sodium acetate (pH 4.5)-10 mM MgCl,-1 mM EDTA.
The bound tRNA was then eluted with 10 ml of 1 M NaCl containing the same additions as the 0.3 M NaCl buffer. tRNA was precipitated by the addition of 3 volumes of cold ethanol. The precipitate was dissolved in 0.05 M Tris-HCl (pH 8.0). esterified glutamic acid, followed by either a spontaneous or enzymatic cyclization, would havc a precedent in similar reactions (17) . Pyroglutamyl-tRNA, as an initiator tRNA, might respond to specific codons and initiation factors. The second suggested mechanism involves the post-translational conversion of protein-bound N-terminal glutamic acid to N-terminal pGlu. This mechanism does not dictate that the protein be initiated by glutamic acid. pGlu might be formed in conjunction with the proteolytic cleavage of an adjacent amino acid or peptide. Further experiments designed to discriminate between these alternative mechanisms are in progress.
Dr. Ettore Appella kindly provided an initial transplant of the mouse plasmacytoma. The conditions for preparing dispersed cell suspensions for amino acid-incorporation studies were developed in this laboratory by Dr. George Jones. Mrs. Helmi Carpenter
